Prazosin Should NOT Be Given PRN for Nightmares
Prazosin must be administered as a scheduled daily medication at bedtime, not as needed (PRN), because it requires consistent dosing and gradual titration to achieve therapeutic effect while minimizing orthostatic hypotension risk. 1
Why PRN Dosing is Inappropriate
The evidence consistently demonstrates that prazosin works through scheduled nightly administration with dose titration, not on-demand use:
Dosing Protocol from Clinical Trials
All successful studies used regular bedtime dosing with the following approach 1:
- Start at 1 mg at bedtime and increase by 1-2 mg every few days until effective dose is reached
- Treatment duration of 3-9 weeks was needed in controlled trials to demonstrate efficacy
- Effective doses ranged from 1-15 mg nightly (average 3-13 mg depending on population)
- Some protocols included a mid-morning dose in addition to bedtime dosing 2
Pharmacologic Rationale Against PRN Use
Prazosin's mechanism requires sustained alpha-1 adrenergic blockade to reduce CNS noradrenergic hyperactivity that underlies PTSD nightmares 1. This is not an acute intervention—it modulates the underlying pathophysiology through consistent receptor antagonism.
Critical evidence: When prazosin was discontinued in responsive patients, they "frequently returned to their baseline nightmare intensity" 2, demonstrating the need for continuous therapy rather than intermittent use.
Safety Concerns with PRN Dosing
Orthostatic hypotension is the primary safety concern and occurs particularly with:
- First doses 1
- Dose increases
- Inconsistent dosing patterns
The FDA label explicitly requires monitoring for hypotension after the first dose 3, which would be impractical and dangerous with PRN administration. Scheduled dosing allows patients to take the medication before bed, minimizing fall risk during the vulnerable period of orthostatic effects.
Proper Administration Strategy
For PTSD-associated nightmares (Level A recommendation) 1:
- Initiate at 1 mg at bedtime
- Increase by 1-2 mg every 3-7 days based on response and tolerability
- Target dose: 3-15 mg nightly (higher doses of 15-20 mg may be needed in military populations)
- Monitor blood pressure after initial dose and with increases
- Continue as scheduled daily therapy, not PRN
If adding other antihypertensives: Reduce prazosin to 1-2 mg three times daily and retitrate 3
Clinical Pitfalls to Avoid
- Do not prescribe PRN—this negates the therapeutic mechanism and increases hypotension risk
- Do not skip the titration period—starting at higher doses increases adverse effects
- Do not discontinue abruptly in responders—nightmares return to baseline 2
- Do not use as monotherapy—most effective when combined with ongoing psychotherapy and/or antidepressants 4
Evidence Quality Note
While the 2010 AASM guidelines gave prazosin a Level A recommendation for PTSD nightmares 1, the 2018 position paper notes this was downgraded due to a large negative trial 2. However, even in studies showing benefit, all used scheduled daily dosing, never PRN administration. The most recent 2025 meta-analysis confirms prazosin significantly improves nightmares (SMD = -0.641, p = 0.025) with scheduled dosing protocols 5.